Literature DB >> 24187462

Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.

Bin Zhang1, Cheng-Gang Zhang, Quan-Bo Zhou, Wei Chen, Zhi-Yong Wu.   

Abstract

AIM: To evaluate the effects of estrogen (E2) on systemic and splanchnic hyperdynamic circulation in portal hypertensive rats.
METHODS: Fifty castrated female Sprague-Dawley rats were divided into five groups: sham operation (SO), partial portal vein ligation (PPVL) + placebo (PLAC), PPVL + E2, PPVL + ICI and PPVL + E2 + ICI. Hemodynamic measurements were performed using ultrasonography. Mesenteric arteriole contractility in response to norepinephrine was determined using a vessel perfusion system. Oxidative stress in the mesenteric artery was investigated by in situ detection of the superoxide anion (O2•(-)) and hydrogen peroxide (H2O2) concentrations.
RESULTS: Treatment with E2 resulted in a significant decrease of portal pressure (P < 0.01) and portal venous inflow (P < 0.05), and higher systemic vascular resistance (P < 0.05) and splanchnic arteriolar resistance (P < 0.01) in PPVL + E2 rats compared to PPVL + PLAC rats. In the mesenteric arterioles of PPVL + E2 rats, the dose-response curve was shifted left, and the EC50 was decreased (P < 0.01). E2 reduced O2•(-) production and H2O2 concentration in the mesenteric artery. However, ICI182, 780 reversed the beneficial effects of E2, therefore, the systemic and splanchnic hyperdynamic circulation were more deteriorated in ICI182, 780-treated rats.
CONCLUSION: Treatment with estrogen improved the systemic and splanchnic hyperdynamic circulation in PPVL rats, in part due to the alleviation of oxidative stress.

Entities:  

Keywords:  Estrogen; Hyperdynamic circulation; Oxidative stress; Partial portal vein ligation

Mesh:

Substances:

Year:  2013        PMID: 24187462      PMCID: PMC3812486          DOI: 10.3748/wjg.v19.i40.6863

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Nitroglycerine effects on portal vein mechanics and oxidative stress in portal hypertension.

Authors:  Andreja Vujanac; Vladimir Jakovljevic; Dusica Djordjevic; Vladimir Zivkovic; Mirjana Stojkovic; Dragan Celikovic; Nebojsa Andjelkovic; Aleksandra Jurisic Skevin; Dragan Djuric
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

2.  Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury.

Authors:  Katalin Szöcs; Bernard Lassègue; Dan Sorescu; Lula L Hilenski; Liisa Valppu; Tracey L Couse; Josiah N Wilcox; Mark T Quinn; J David Lambeth; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

3.  Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.

Authors:  M Sakamoto; T Ueno; T Nakamura; R Sakata; O Hasimoto; T Torimura; M Sata
Journal:  Eur J Clin Invest       Date:  2005-03       Impact factor: 4.686

4.  N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.

Authors:  B Fernando; R Marley; S Holt; R Anand; D Harry; P Sanderson; R Smith; G Hamilton; K Moore
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

Review 5.  Cirrhosis of the liver and receptor-mediated function in vascular smooth muscle.

Authors:  P W Hadoke
Journal:  Pharmacol Ther       Date:  2001-03       Impact factor: 12.310

6.  Gender differences in vascular reactivity of aortas from rats with and without portal hypertension.

Authors:  René Robert; Carine Chagneau-Derrode; Michel Carretier; Gérard Mauco; Christine Silvain
Journal:  J Gastroenterol Hepatol       Date:  2005-06       Impact factor: 4.029

7.  Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.

Authors:  Ming-Hung Tsai; Yasuko Iwakiri; Gregory Cadelina; William C Sessa; Roberto J Groszmann
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

8.  The effects of estrogen and raloxifene treatment on antioxidant enzymes in brain and liver of ovarectomized female rats.

Authors:  Mert Ozgönül; Ayşin Oge; Ebru Demirel Sezer; Firat Bayraktar; Eser Yildirim Sözmen
Journal:  Endocr Res       Date:  2003-05       Impact factor: 1.720

9.  Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats.

Authors:  Andrea J Moreira; Christina Fraga; María Alonso; Pilar S Collado; Claudio Zetller; Claudio Marroni; Norma Marroni; Javier González-Gallego
Journal:  Biochem Pharmacol       Date:  2004-11-15       Impact factor: 5.858

10.  Modulation of antioxidant enzyme expression and function by estrogen.

Authors:  Kerstin Strehlow; Simone Rotter; Sven Wassmann; Oliver Adam; Christian Grohé; Kerstin Laufs; Michael Böhm; Georg Nickenig
Journal:  Circ Res       Date:  2003-06-19       Impact factor: 17.367

View more
  3 in total

1.  Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase Expression.

Authors:  Thomas J Lechuga; Hong-hai Zhang; Lili Sheibani; Muntarin Karim; Jason Jia; Ronald R Magness; Charles R Rosenfeld; Dong-bao Chen
Journal:  Endocrinology       Date:  2015-03-31       Impact factor: 4.736

2.  Gender differences in esophageal variceal bleeding in the United States.

Authors:  Aalam Sohal; Hunza Chaudhry; Armaan Dhaliwal; Piyush Singla; Gagan Gupta; Raghav Sharma; Dino Dukovic; Devang Prajapati
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.

Authors:  Bin Zhang; Lin-Hua Ji; Cheng-Gang Zhang; Gang Zhao; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.